ID   MARCS_RAT               Reviewed;         309 AA.
AC   P30009; P20468;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-OCT-2024, entry version 137.
DE   RecName: Full=Myristoylated alanine-rich C-kinase substrate;
DE            Short=MARCKS;
DE   AltName: Full=Protein kinase C substrate 80 kDa protein;
GN   Name=Marcks; Synonyms=Macs;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=1707878; DOI=10.1016/s0021-9258(20)89611-2;
RA   Erusalimsky J.D., Brooks S.F., Herget T., Morris C., Rozengurt E.;
RT   "Molecular cloning and characterization of the acidic 80-kDa protein kinase
RT   C substrate from rat brain. Identification as a glycoprotein.";
RL   J. Biol. Chem. 266:7073-7080(1991).
RN   [2]
RP   PROTEIN SEQUENCE OF 12-31; 189-217; 252-275 AND 300-309.
RC   TISSUE=Brain;
RX   PubMed=2676596; DOI=10.1016/0014-5793(89)81079-8;
RA   Erusalimsky J.D., Morris C., Perks K., Brown R., Brooks S., Rozengurt E.;
RT   "Internal amino acid sequence analysis of the 80 kDa protein kinase C
RT   substrate from rat brain: relationship to the 87 kDa substrate from bovine
RT   brain.";
RL   FEBS Lett. 255:149-153(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 182-301, AND TISSUE SPECIFICITY.
RX   PubMed=1396720; DOI=10.1111/j.1432-1033.1992.tb17255.x;
RA   Herget T., Brooks S.F., Broad S., Rozengurt E.;
RT   "Relationship between the major protein kinase C substrates acidic 80-kDa
RT   protein-kinase-C substrate (80K) and myristoylated alanine-rich C-kinase
RT   substrate (MARCKS). Members of a gene family or equivalent genes in
RT   different species.";
RL   Eur. J. Biochem. 209:7-14(1992).
RN   [4]
RP   PHOSPHORYLATION AT SER-152; SER-156 AND SER-163.
RC   TISSUE=Brain;
RX   PubMed=8422248; DOI=10.1006/bbrc.1993.1036;
RA   Heemskerk F.M., Chen H.C., Huang F.L.;
RT   "Protein kinase C phosphorylates Ser-152, Ser-156 and Ser-163 but not Ser-
RT   160 of MARCKS in rat brain.";
RL   Biochem. Biophys. Res. Commun. 190:236-241(1993).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26; SER-27; SER-29; SER-46;
RP   SER-63; SER-74; THR-79; SER-113; SER-122; SER-138; THR-143; SER-156;
RP   SER-160; SER-163 AND SER-218, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   FUNCTION, INTERACTION WITH RAB10, AND SUBCELLULAR LOCATION.
RX   PubMed=24662485; DOI=10.1038/cr.2014.33;
RA   Xu X.H., Deng C.Y., Liu Y., He M., Peng J., Wang T., Yuan L., Zheng Z.S.,
RA   Blackshear P.J., Luo Z.G.;
RT   "MARCKS regulates membrane targeting of Rab10 vesicles to promote axon
RT   development.";
RL   Cell Res. 24:576-594(2014).
CC   -!- FUNCTION: Membrane-associated protein that plays a role in the
CC       structural modulation of the actin cytoskeleton, chemotaxis, motility,
CC       cell adhesion, phagocytosis, and exocytosis through lipid sequestering
CC       and/or protein docking to membranes (PubMed:24662485). Thus, exerts an
CC       influence on a plethora of physiological processes, such as embryonic
CC       development, tissue regeneration, neuronal plasticity, and
CC       inflammation. Sequesters phosphatidylinositol 4,5-bisphosphate (PIP2)
CC       at lipid rafts in the plasma membrane of quiescent cells, an action
CC       reversed by protein kinase C, ultimately inhibiting exocytosis. During
CC       inflammation, promotes the migration and adhesion of inflammatory cells
CC       and the secretion of cytokines such as tumor necrosis factor (TNF),
CC       particularly in macrophages. Plays an essential role in bacteria-
CC       induced intracellular reactive oxygen species (ROS) formation in the
CC       monocytic cell type. Participates in the regulation of neurite
CC       initiation and outgrowth by interacting with components of cellular
CC       machinery including CDC42 that regulates cell shape and process
CC       extension through modulation of the cytoskeleton (By similarity). Plays
CC       also a role in axon development by mediating docking and fusion of
CC       RAB10-positive vesicles with the plasma membrane (PubMed:24662485).
CC       {ECO:0000250|UniProtKB:P26645, ECO:0000250|UniProtKB:P29966,
CC       ECO:0000269|PubMed:24662485}.
CC   -!- SUBUNIT: Interacts with CDC42 (By similarity). Interacts with GTP-bound
CC       form of RAB10 (PubMed:24662485). Interacts with calmodulin/CALM1 (By
CC       similarity). {ECO:0000250|UniProtKB:P26645,
CC       ECO:0000269|PubMed:24662485}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:24662485};
CC       Lipid-anchor {ECO:0000269|PubMed:24662485}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P29966}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P29966}. Note=PKC-dependent phosphorylation
CC       displaces MARCKS from the cell membrane and subsequent
CC       dephosphorylation is accompanied by its reassociation with the
CC       membrane. {ECO:0000250|UniProtKB:P29966}.
CC   -!- TISSUE SPECIFICITY: Highest levels found in spleen and brain.
CC       Intermediate levels seen in thymus, ovary, lung and heart. Very low
CC       levels seen in kidney, skeletal muscle and liver.
CC       {ECO:0000269|PubMed:1396720}.
CC   -!- PTM: Acetylated at Lys-165 by KAT5; acetylation is required for its
CC       subsequent phosphorylation. Deacetylated by SIRT2.
CC       {ECO:0000250|UniProtKB:P26645}.
CC   -!- PTM: Phosphorylation by PKC displaces MARCKS from the membrane. It also
CC       inhibits the F-actin cross-linking activity.
CC       {ECO:0000269|PubMed:8422248}.
CC   -!- PTM: Myristoylated. A proper myristoylation is essential for the proper
CC       distribution to the plasma membrane. {ECO:0000250|UniProtKB:P29966}.
CC   -!- SIMILARITY: Belongs to the MARCKS family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M59859; -; NOT_ANNOTATED_CDS; mRNA.
DR   PIR; A39773; A39773.
DR   AlphaFoldDB; P30009; -.
DR   IntAct; P30009; 3.
DR   STRING; 10116.ENSRNOP00000000707; -.
DR   GlyGen; P30009; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P30009; -.
DR   PhosphoSitePlus; P30009; -.
DR   jPOST; P30009; -.
DR   PaxDb; 10116-ENSRNOP00000000707; -.
DR   Ensembl; ENSRNOT00055001116; ENSRNOP00055000874; ENSRNOG00055000650.
DR   Ensembl; ENSRNOT00055020667; ENSRNOP00055016657; ENSRNOG00055012162.
DR   Ensembl; ENSRNOT00060012059; ENSRNOP00060009091; ENSRNOG00060007330.
DR   Ensembl; ENSRNOT00065013747; ENSRNOP00065010196; ENSRNOG00065008662.
DR   UCSC; RGD:3028; rat.
DR   AGR; RGD:3028; -.
DR   RGD; 3028; Marcks.
DR   eggNOG; ENOG502RB4V; Eukaryota.
DR   InParanoid; P30009; -.
DR   Reactome; R-RNO-399997; Acetylcholine regulates insulin secretion.
DR   PRO; PR:P30009; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0032432; C:actin filament bundle; ISO:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0032059; C:bleb; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0033391; C:chromatoid body; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0044307; C:dendritic branch; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0042585; C:germinal vesicle; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0030426; C:growth cone; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005874; C:microtubule; IDA:RGD.
DR   GO; GO:0043226; C:organelle; ISO:RGD.
DR   GO; GO:0001520; C:outer dense fiber; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0099571; C:postsynaptic cytoskeleton; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0099523; C:presynaptic cytosol; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0051015; F:actin filament binding; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0001786; F:phosphatidylserine binding; IDA:RGD.
DR   GO; GO:0005543; F:phospholipid binding; IDA:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; ISO:RGD.
DR   GO; GO:0051764; P:actin crosslink formation; ISO:RGD.
DR   GO; GO:0051017; P:actin filament bundle assembly; ISO:RGD.
DR   GO; GO:0007015; P:actin filament organization; IMP:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0031589; P:cell-substrate adhesion; IDA:RGD.
DR   GO; GO:0007417; P:central nervous system development; IBA:GO_Central.
DR   GO; GO:0006886; P:intracellular protein transport; IMP:RGD.
DR   GO; GO:0007005; P:mitochondrion organization; ISO:RGD.
DR   GO; GO:0021915; P:neural tube development; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; ISO:RGD.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IMP:RGD.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:1905274; P:regulation of modification of postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; ISO:RGD.
DR   GO; GO:0003229; P:ventricular cardiac muscle tissue development; IEP:RGD.
DR   InterPro; IPR002101; MARCKS.
DR   PANTHER; PTHR14353:SF9; MYRISTOYLATED ALANINE-RICH C-KINASE SUBSTRATE; 1.
DR   PANTHER; PTHR14353; MYRISTOYLATED ALANINE-RICH C-KINASE SUBSTRATE MARCKS; 1.
DR   Pfam; PF02063; MARCKS; 1.
DR   PRINTS; PR00963; MARCKS.
DR   PROSITE; PS00826; MARCKS_1; 1.
DR   PROSITE; PS00827; MARCKS_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Calmodulin-binding; Cell membrane; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Lipoprotein; Membrane; Myristate;
KW   Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P12624"
FT   CHAIN           2..309
FT                   /note="Myristoylated alanine-rich C-kinase substrate"
FT                   /id="PRO_0000157150"
FT   REGION          1..309
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          145..169
FT                   /note="Calmodulin-binding (PSD)"
FT   COMPBIAS        117..134
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        163..183
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        234..251
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        293..309
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         46
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         79
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         128
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P12624"
FT   MOD_RES         138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29966"
FT   MOD_RES         141
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26645"
FT   MOD_RES         143
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         152
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:8422248"
FT   MOD_RES         156
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:8422248,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         163
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:8422248,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         165
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P26645"
FT   MOD_RES         218
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         246
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26645"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29966"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250|UniProtKB:P29966"
FT   CONFLICT        29
FT                   /note="S -> G (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        183
FT                   /note="D -> E (in Ref. 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        216
FT                   /note="G -> E (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   309 AA;  29795 MW;  9957F2037F203316 CRC64;
     MGAQFSKTAA KGEAAAERPG EAAVASSPSK ANGQENGHVK VNGDASPAAA EPGAKEELQA
     NGSAPAADKE EPASGGAATP AAADKDEAAA APEPGAATAD KEAAEAEPAE PGSPSAETEG
     ASASSTSSPK AEDGAAPSPS SETPKKKKKR FSFKKSFKLS GFSFKKSKKE AGEGAEAEGA
     TADGAKDEAA AAAGGDAAAA PGEQAGGAGA EGAEGGESRE AEAAEPEQPE QPEQPAAEEP
     RAEEPSEAVG EKAEEPAPGA TADDAPSAAG PEQEAPAATD EPAASAAPSA SPEPQPECSP
     EAPPAPVAE
//
